- Home
- PWR vs ALC Comparison
PWR vs ALC Comparison
Compare PWR & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWR
- ALC
- Stock Information
- Founded
- PWR 1997
- ALC 1945
- Country
- PWR United States
- ALC Switzerland
- Employees
- PWR N/A
- ALC N/A
- Industry
- PWR Engineering & Construction
- ALC Ophthalmic Goods
- Sector
- PWR Industrials
- ALC Health Care
- Exchange
- PWR Nasdaq
- ALC Nasdaq
- Market Cap
- PWR 44.7B
- ALC 41.0B
- IPO Year
- PWR 1998
- ALC N/A
- Fundamental
- Price
- PWR $269.57
- ALC $90.33
- Analyst Decision
- PWR Strong Buy
- ALC Strong Buy
- Analyst Count
- PWR 18
- ALC 13
- Target Price
- PWR $330.81
- ALC $102.91
- AVG Volume (30 Days)
- PWR 1.8M
- ALC 1.5M
- Earning Date
- PWR 02-20-2025
- ALC 02-25-2025
- Dividend Yield
- PWR 0.15%
- ALC 0.29%
- EPS Growth
- PWR 20.60
- ALC 156.61
- EPS
- PWR 6.03
- ALC 2.34
- Revenue
- PWR $23,672,795,000.00
- ALC $9,761,000,000.00
- Revenue This Year
- PWR $14.79
- ALC $5.43
- Revenue Next Year
- PWR $12.81
- ALC $6.37
- P/E Ratio
- PWR $44.69
- ALC $38.13
- Revenue Growth
- PWR 13.36
- ALC 5.25
- 52 Week Low
- PWR $227.11
- ALC $77.54
- 52 Week High
- PWR $365.88
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- PWR 30.70
- ALC 55.09
- Support Level
- PWR $281.54
- ALC $88.56
- Resistance Level
- PWR $309.41
- ALC $90.74
- Average True Range (ATR)
- PWR 12.11
- ALC 1.22
- MACD
- PWR -2.69
- ALC -0.24
- Stochastic Oscillator
- PWR 3.24
- ALC 45.64
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under three reportable segments: electric power, renewables infrastructure, and underground utility and infrastructure.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.